XRHealth Receives Patent to Measure Sway & Conduct Fall Risk Assessment in Virtual Reality & Augmented Reality Therapy

XRHealth, the leader in extended reality and therapeutic telehealth applications, announces today that they received a patent to measure sway and conduct a fall risk assessment using virtual reality and augmented reality therapy.

According to the CDC, one out of five falls results in serious complications like broken bones or head injury. With the new capability, XRHealth can assess the risk of elderly patients’ likelihood of falling, potentially preventing a debilitating injury.

The patent is entitled “Assessing Postural Sway in Virtual Reality or Augmented Reality.” Sway is measured by using a VR/AR platform to measure positional data from a headset or hand sensors. The positional data then determines the center of mass. When the patient enters the virtual/augmented reality environment, it simulates a situation where the user is unbalanced. The data on position and center of mass is then sent to a server to determine if the person poses a risk for falling.

Three million elderly people are sent to emergency rooms each year to treat injuries from falls and 95% of hip fractures are a result of falls. “When treating elderly patients, the ability to measure sway accurately in an AR/VR therapeutic process can potentially prevent falls that can result in long-term disabilities,” said Eran Orr, CEO of XRHealth. “The advantage of using XR to measure sway is that patients can do this from the comfort of their home, during routine extended reality therapy.”

XRHealth has virtual clinics throughout the United States that treat patients remotely with VR/AR-based therapy while they are examined by a licensed XRHealth therapist. The XRHealth platform combines FDA-registered medical applications with advanced data analytics, providing a comprehensive solution for therapists and patients while collecting and analyzing patient interactions with virtual objects in virtual environments.

 

SourceXRHealth

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.